MedTrace Logo

Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers

NCT01707940 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2013-05-16

No results posted yet for this study

Summary

This trial investigates the influence of oral ketoconazole on the pharmacokinetics and safety of BI 144807.

Conditions

  • Healthy

Interventions

DRUG

Ketoconazole

Ketoconazole 400 mg / day

DRUG

BI 144807

BI144807 oral solution, intermediate dose

DRUG

BI 144807

BI144807 oral solution, intermediate dose

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01707940 on ClinicalTrials.gov